BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 12646661)

  • 1. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
    Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
    J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
    Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
    J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus.
    Zeller GC; Hirahashi J; Schwarting A; Sharpe AH; Kelley VR
    J Am Soc Nephrol; 2006 Jan; 17(1):122-30. PubMed ID: 16291836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis.
    Fan X; Wüthrich RP
    Inflammation; 1997 Feb; 21(1):105-12. PubMed ID: 9179626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice.
    Menke J; Bork T; Kutska B; Byrne KT; Blanfeld M; Relle M; Kelley VR; Schwarting A
    Kidney Int; 2011 Feb; 79(4):452-63. PubMed ID: 20980973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine production of IFN-gamma by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice.
    Carvalho-Pinto CE; García MI; Mellado M; Rodríguez-Frade JM; Martín-Caballero J; Flores J; Martínez-A C; Balomenos D
    J Immunol; 2002 Jul; 169(2):1058-67. PubMed ID: 12097414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of IL-18 receptor signaling delays the onset of autoimmune disease in MRL-Faslpr mice.
    Kinoshita K; Yamagata T; Nozaki Y; Sugiyama M; Ikoma S; Funauchi M; Kanamaru A
    J Immunol; 2004 Oct; 173(8):5312-8. PubMed ID: 15470078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
    Iwata Y; Boström EA; Menke J; Rabacal WA; Morel L; Wada T; Kelley VR
    J Immunol; 2012 May; 188(9):4568-80. PubMed ID: 22467656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
    Moore KJ; Yeh K; Naito T; Kelley VR
    J Immunol; 1996 Jul; 157(1):427-32. PubMed ID: 8683148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(lpr) mice with renal injury.
    Fan X; Oertli B; Wüthrich RP
    Kidney Int; 1997 Jan; 51(1):79-86. PubMed ID: 8995720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets.
    Wada T; Schwarting A; Chesnutt MS; Wofsy D; Rubin Kelley V
    Kidney Int; 2001 Feb; 59(2):565-78. PubMed ID: 11168938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice.
    Kinoshita K; Tesch G; Schwarting A; Maron R; Sharpe AH; Kelley VR
    J Immunol; 2000 Jun; 164(11):6046-56. PubMed ID: 10820290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.